Cargando…

Microsatellite instability and mutations in BRAF and KRAS are significant predictors of disseminated disease in colon cancer

BACKGROUND: Molecular alterations are well studied in colon cancer, however there is still need for an improved understanding of their prognostic impact. This study aims to characterize colon cancer with regard to KRAS, BRAF, and PIK3CA mutations, microsatellite instability (MSI), and average DNA co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Birgisson, Helgi, Edlund, Karolina, Wallin, Ulrik, Påhlman, Lars, Kultima, Hanna Göransson, Mayrhofer, Markus, Micke, Patrick, Isaksson, Anders, Botling, Johan, Glimelius, Bengt, Sundström, Magnus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4364587/ https://www.ncbi.nlm.nih.gov/pubmed/25884297 http://dx.doi.org/10.1186/s12885-015-1144-x

Ejemplares similares

1p36 deletion is a marker for tumour dissemination in microsatellite stable stage II-III colon cancer
por: Mayrhofer, Markus, et al.
Publicado: (2014)

Allele-specific copy number analysis of tumor samples with aneuploidy and tumor heterogeneity
por: Rasmussen, Markus, et al.
Publicado: (2011)

KRAS analysis in colorectal carcinoma: Analytical aspects of Pyrosequencing and allele-specific PCR in clinical practice
por: Sundström, Magnus, et al.
Publicado: (2010)

Survival endpoints in colorectal cancer and the effect of second primary other cancer on disease free survival
por: Birgisson, Helgi, et al.
Publicado: (2011)

Prognostic Impact of BRAF and KRAS Mutation in Patients with Colorectal and Appendiceal Peritoneal Metastases Scheduled for CRS and HIPEC
por: Graf, Wilhelm, et al.
Publicado: (2019)

Genomic and Transcriptional Alterations in Lung Adenocarcinoma in Relation to EGFR and KRAS Mutation Status
por: Planck, Maria, et al.
Publicado: (2013)

Detection of Biomarkers with Solid-Phase Proximity Ligation Assay in Patients with Colorectal Cancer
por: Ghanipour, Lana, et al.
Publicado: (2016)

Microsatellite instability in sporadic colorectal cancer is not an independent prognostic factor
por: Salahshor, S, et al.
Publicado: (1999)

Targeted resequencing of candidate genes using selector probes
por: Johansson, H., et al.
Publicado: (2011)

Consequences of a high incidence of microsatellite instability and BRAF‐mutated tumors: A population‐based cohort of metastatic colorectal cancer patients
por: Aasebø, Kristine Ø., et al.
Publicado: (2019)

External validation of molecular subtype classifications of colorectal cancer based on microsatellite instability, CIMP, BRAF and KRAS
por: Alwers, Elizabeth, et al.
Publicado: (2019)

KRAS, NRAS, BRAF, HER2 and Microsatellite Instability in Metastatic Colorectal Cancer – Practical Implications for the Clinician
por: Afrăsânie, Vlad-Adrian, et al.
Publicado: (2019)

Colorectal cancer molecular classification using BRAF, KRAS, microsatellite instability and CIMP status: Prognostic implications and response to chemotherapy
por: Murcia, Oscar, et al.
Publicado: (2018)

Genomic Profiling for KRAS, NRAS, BRAF, Microsatellite Instability, and Mismatch Repair Deficiency Among Patients With Metastatic Colon Cancer
por: Gutierrez, Martin E., et al.
Publicado: (2019)

High frequency of microsatellite instability and its substantial co-existence with KRAS and BRAF mutations in Vietnamese patients with colorectal cancer
por: Nguyen, Ha Thi, et al.
Publicado: (2021)

High BRAF Mutation Frequency and Marked Survival Differences in Subgroups According to KRAS/BRAF Mutation Status and Tumor Tissue Availability in a Prospective Population-Based Metastatic Colorectal Cancer Cohort
por: Sorbye, Halfdan, et al.
Publicado: (2015)

CDX2: A Prognostic Marker in Metastatic Colorectal Cancer Defining a Better BRAF Mutated and a Worse KRAS Mutated Subgroup
por: Aasebø, Kristine, et al.
Publicado: (2020)

Growth differentiation factor 15: a prognostic marker for recurrence in colorectal cancer
por: Wallin, U, et al.
Publicado: (2011)

Impact of microsatellite status on chemotherapy for colorectal cancer patients with KRAS or BRAF mutation
por: Huang, Chi-Jung, et al.
Publicado: (2016)

Signet Ring Cell Colorectal and Appendiceal Cancer: A Small Signet Ring Cell Component Is Also Associated with Poor Outcome
por: Enblad, Malin, et al.
Publicado: (2023)

Chromosomal Instability in BRAF Mutant, Microsatellite Stable Colorectal Cancers
por: Bond, Catherine E., et al.
Publicado: (2012)

Impact of KRAS, BRAF and microsatellite instability status after cytoreductive surgery and HIPEC in a national cohort of colorectal peritoneal metastasis patients
por: Larsen, S. G., et al.
Publicado: (2021)

Molecular Profiling Based on KRAS/BRAF Mutation, Methylation, and Microsatellite Statuses in Serrated Lesions
por: Sugai, Tamotsu, et al.
Publicado: (2018)

Prognostic Value of Autophagy, Microsatellite Instability, and KRAS Mutations in Colorectal Cancer
por: Wang, Yuanyuan, et al.
Publicado: (2021)

Combination of microsatellite instability and BRAF mutation status for subtyping colorectal cancer
por: Seppälä, T T, et al.
Publicado: (2015)

Prognostic value of the combination of microsatellite instability and BRAF mutation in colorectal cancer
por: Yang, Yingchi, et al.
Publicado: (2018)

Quantification of Normal Cell Fraction and Copy Number Neutral LOH in Clinical Lung Cancer Samples Using SNP Array Data
por: Göransson, Hanna, et al.
Publicado: (2009)

Analysis of KRAS, NRAS, and BRAF Mutations, Microsatellite Instability, and Relevant Prognosis Effects in Patients With Early Colorectal Cancer: A Cohort Study in East Asia
por: Li, Yang, et al.
Publicado: (2022)

Primary glioblastoma cells for precision medicine: a quantitative portrait of genomic (in)stability during the first 30 passages
por: Baskaran, Sathishkumar, et al.
Publicado: (2018)

In situ mutation detection and visualization of intratumor heterogeneity for cancer research and diagnostics
por: Grundberg, Ida, et al.
Publicado: (2013)

KRAS and BRAF mutations in circulating tumour DNA from locally advanced rectal cancer
por: Sclafani, Francesco, et al.
Publicado: (2018)

Magnetic resonance imaging (MRI) in rectal cancer: a comprehensive review
por: Torkzad, Michael R., et al.
Publicado: (2010)

Microsatellite Instability, KRAS Mutations and Cellular Distribution of TRAIL-Receptors in Early Stage Colorectal Cancer
por: Kriegl, Lydia, et al.
Publicado: (2012)

Correlations among KRAS Mutation, Microsatellite Instability, and (18)F-FDG Uptake in Colon Cancer
por: Lee, Sun Seong, et al.
Publicado: (2022)

The role of autophagy in the treatment of BRAF mutant colorectal carcinomas differs based on microsatellite instability status
por: Koustas, Evangelos, et al.
Publicado: (2018)

Editorial: Microsatellite and microsatellite instability
por: How-Kit, Alexandre, et al.
Publicado: (2023)

Complete response with combined BRAF and MEK inhibition in BRAF mutated advanced low-grade serous ovarian carcinoma
por: Tholander, Bengt, et al.
Publicado: (2020)

BRAF-Mutated Colorectal Cancer Exhibits Distinct Clinicopathological Features from Wild-Type BRAF-Expressing Cancer Independent of the Microsatellite Instability Status
por: Jang, Min Hye, et al.
Publicado: (2017)

Impact of BRAF, MLH1 on the incidence of microsatellite instability high colorectal cancer in populations based study
por: Brim, Hassan, et al.
Publicado: (2008)

CpG Island Methylation, Microsatellite Instability, and BRAF Mutations and Their Clinical Application in the Treatment of Colon Cancer
por: Wu, Christina, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_gu45m87hdre174e6jb8n7218id